Toxic epidermal necrolysis and clarithromycin

Canadian Journal of Clinical Pharmacology

Volumn 12, Issue 3, 2005, Pages

  Khaldi, Nadia ^a   Miras, Alain ^a   Gromb, Sophie ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b University of Medicine   (France)

Author keywords

Causality; Clarithromycin; Macrolide; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CLARITHROMYCIN; DOXICLINE; DOXYCYCLINE; ERDOSTEINE; GENTAMICIN; LYSINE ACETYLSALICYLATE; MACROLIDE; PARACETAMOL; ROXITHROMYCIN; VANCOMYCIN;

ADULT; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; DRUG SUBSTITUTION; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MICROBIOLOGICAL EXAMINATION; PNEUMONIA; PRURITUS; SKIN BIOPSY; STAPHYLOCOCCUS INFECTION; STEVENS JOHNSON SYNDROME; TONSILLITIS; TOXIC EPIDERMAL NECROLYSIS; UPPER RESPIRATORY TRACT INFECTION; VESICULAR RASH;

EID: 30744453767     PISSN: 1198581X     EISSN: 17106222     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wolkenstein P, Roujeau JC, Revuz J. Drug induced Toxic Epidermal Necrolysis. Clinics in dermatology 1998;16:399-409
2. Roujeau JC, Stern R. Severe adverse cutaneous reactions to drugs. The New England Journal of Medicine 1994;331:1272-85.
3. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. The Lancet 2000;356:1587-91.
4. Roujeau JC. Toxidermies médicamenteuses: quelques nouveautés. Revue Française d'allergologie immunologie clinique 2002;42:71-74.
5. Paquet P. Drugs involved in Toxic Epidermal Necrolysis. Thérapie 1993;48(2):133-139.
6. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and risk of Steven-Johnson syndrome or Toxic Epidermal Necrolysis. The New England Journal of Medicine, 1995;333(24):1600-7.
7. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-492.
8. Schnyder B, Burkhart C, Schnyder-Frutig K, et al. Recognition of sulfomethoxazole and its reactive metabolites by drug-specific CD4+T cells from allergic individuals. J Immunol 2000;164:6647-54.
9. Yawallkar N, et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. Allergy Clinic Immunol 2000;106:1171-6.
10. Hans C, Paquet C, Maréchal-Courtois C. Le traitement ophtalmologique du Syndrome de Lyell. Revue Médicale de Liège, XLVIII;7-93.
11. Becker SD. Toxic epidermal necrolysis. The Lancet 1998;351:1417-20.
12. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisées en France. Thérapie 1985;40:111-118